Skip to main content

Table 2 Breakdown of antidepressants use in the study group (n = 866)

From: Estimating the risk of irreversible post-SSRI sexual dysfunction (PSSD) due to serotonergic antidepressants

Antidepressants used per patient—n (%)

 

One

662 (76.4%)

Two

148 (17.1%)

Three

48 (5.5%)

Four or More

26 (0.9%)

Serotonergic antidepressants used—n (%)

 

SSRIs

892 (79.9%)

TCAs

135 (15.6%)

SNRIs

70 (8.1%)

Hypericum

53 (6.1%)

Mirtazapine

23 (2.7%)

Mianserin

13 (1.5%)

Trazodone

7 (0.8%)

Vortioxetine

3 (0.3%)

Maprotiline

2 (0.2%)

Phenelzine

1 (0.1%)